Fabry disease (alpha-galactosidase A deficiency): renal involvement and enzyme replacement therapy.
Desnick
R J
RJ
Department of Human Genetics, Mount Sinai School of Medicine of New York University, New York, N.Y., USA. rjdesnick@mssm.edu
Wasserstein
M P
MP
Banikazemi
M
M
D002986:Clinical Trials as Topic; D000795:Fabry Disease / Q000150:complications* / Q000235:genetics / Q000628:therapy; D005260:Female; D006801:Humans; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000209:etiology*; D016030:Kidney Transplantation; D008297:Male; D006435:Renal Dialysis; D000519:alpha-Galactosidase / Q000627:therapeutic use*
D000519:alpha-Galactosidase